Hypothesis: Thanks to a stronger weight loss, CagriSema should lead to a superior reduction of MACE compared to Semaglutide in SELECT (where Semaglutide reduced MACE by 20 %)
This synergy has led to growing interest in studying their combined potential in wound recovery models, muscle regeneration, and neurovascular protection
BPC-157's documented ability to modulate the nitric oxide pathway and reduce inflammatory cytokine expression in animal models suggests a potential role in the anti-inflammatory toolkit available to longevity-focused medicine, though this remains an extrapolation requiring human validation
Research shows that its angiogenic and anti-inflammatory benefits may extend beyond the digestive system even in small doses
NAD+ Support your energy, focus, and overall wellness with provider-guided NAD+ therapy
+ Riboflavin-B2 Helps metabolize fats, carbs, and respiratory proteins